Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3133370
Max Phase: Preclinical
Molecular Formula: C46H65N9O11S2
Molecular Weight: 984.21
Molecule Type: Small molecule
Associated Items:
ID: ALA3133370
Max Phase: Preclinical
Molecular Formula: C46H65N9O11S2
Molecular Weight: 984.21
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCCCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C46H65N9O11S2/c1-25(2)38-44(63)50-26(3)40(59)52-34(20-28-15-17-30(57)18-16-28)42(61)48-19-11-7-5-6-8-14-37(58)51-35(21-29-22-49-33-13-10-9-12-31(29)33)43(62)55-39(27(4)56)45(64)53-36(46(65)66)24-68-67-23-32(47)41(60)54-38/h9-10,12-13,15-18,22,25-27,32,34-36,38-39,49,56-57H,5-8,11,14,19-21,23-24,47H2,1-4H3,(H,48,61)(H,50,63)(H,51,58)(H,52,59)(H,53,64)(H,54,60)(H,55,62)(H,65,66)/t26-,27+,32-,34-,35-,36-,38-,39-/m0/s1
Standard InChI Key: NTVYIZYCYHVFHR-FTUPMQGGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 984.21 | Molecular Weight (Monoisotopic): 983.4245 | AlogP: 0.89 | #Rotatable Bonds: 7 |
Polar Surface Area: 323.27 | Molecular Species: ACID | HBA: 13 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.55 | CX Basic pKa: 7.65 | CX LogP: -1.72 | CX LogD: -1.89 |
Aromatic Rings: 3 | Heavy Atoms: 68 | QED Weighted: 0.15 | Np Likeness Score: 1.01 |
1. Meinander K, Weisell J, Pakkala M, Tadd AC, Hekim C, Kallionpaa R, Widell K, Stenman U, Koistinen H, Narvanen A, Vepsalainen J, Luthman K, Wallen EAA. (2013) Pseudopeptides with a centrally positioned alkene-based disulphide bridge mimetic stimulate kallikrein-related peptidase 3 activity, 4 (3): [10.1039/C3MD20292E] |
Source(1):